Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
Wednesday, December 18, 2024NANOBIOTIX a lateclinical stage biotechnology company pioneering nanoparticlebased therapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases today announced a virtual event titled Accelerating the Futu...
Candid Therapeutics and EpimAb Biotherapeutics Enter Into Research Collaboration to Discover and Develop Novel T-Cell Engagers for Autoimmune Indications
Tuesday, December 17, 2024Candid Therapeutics Inc a clinicalstage biotechnology company focused on becoming the leader in advancing Tcell engagers for autoimmune diseases and EpimAb Biotherapeutics Inc a clinicalstage biopharmaceutical company specializing in the discovery an...
SK Biopharmaceuticals Inks Research Collaboration Agreement with ProEn Therapeutics Further Accelerating Expansion of Oncology Research and Pipeline for Global Competitiveness in Radiopharmaceuticals
Tuesday, December 17, 2024SK Biopharmaceuticals a biotech company focusing on the research development and commercialization of treatments for disorders of the central nervous system and oncology worldwide announced a research collaboration agreement with ProEn Therapeutics
Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark
Monday, December 16, 2024Novo Nordisk announced plans to invest billion Danish kroner to establish a completely new production facility in Odense Denmark The investment marks the first time in this century that Novo Nordisk breaks ground in Denmark by establishing
CSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema (HAE)
Monday, December 16, 2024Global biotechnology leader CSL announced the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP adopted a positive opinion recommending granting a marketing authorization for garadacimab as a oncemonthly prophylactic...
Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities
Friday, December 13, 2024Roche announced today the CE certification of the new cobas systems The update significantly enhances the efficiency of laboratories by optimising resources reducing downtime consolidating test menus and increasing throughput These improvements ult...
Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis
Thursday, December 12, 2024Enlivex Therapeutics Ltd a clinicalstage macrophage reprogramming immunotherapy company today announced that the Israeli Ministry of Health authorized the initiation of an investigatorinitiated Phase I trial to evaluate the safety tolerability and in...
DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old
Thursday, December 12, 2024DBV Technologies a clinicalstage biopharmaceutical company today announced the successful outcome of recent written and oral communication with the US Food and Drug Administration FDA that provides a clear and welldefined regulatory pathway for the V...
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
Wednesday, December 11, 2024Agilent Technologies Inc announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation IVDR certification for PDL IHC pharmDx Code SK This CDx assay has previously been CEIVDmarked for sales in the European Union and is now...
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
Wednesday, December 11, 2024Zealand Pharma AS a biotechnology company focused on the discovery and development of innovative peptidebased medicines today announced that the first participant has been enrolled in ZUPREME a global Phase b trial in people with obesity or overweigh...
